icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Barcelona, Spain
13-17 April 2016
Back grey_arrow_rt.gif
 
 
 
High sustained virological response rates using generic direct
antiviral treatment for Hepatitis C REDEMPTION-1

 
 
  Reported by Jules Levin
EASL 2016
 
James Freeman1, Richard Sallie2, Adam Kennedy3, Pham Thi Ngoc Nieu1, John Freeman4, Greg Jeffreys5, Andrew M. Hill6
1GP2U Telehealth, Hobart, 2Hepatology, Nedlands, 3Kingswood Pharmacy, 4Nephrology, Sandy Bay, 5University of Tasmania, Hobart, Australia, 6St Stephens AIDS Trust, Chelsea and Westminster Hospital, London, United Kingdom
 
International Liver Congress 2016 13-18 April, Barcelona, Spain

EASL1

 

EASL2

EASL3

1.http://www.who.int/mediacentre/factsheets/fs164/en/
 
2.http://www.unitaid.eu/images/marketdynamics/publications/Hepatitis_C_Medicines_Technology_and_Market_Landscape__Update.pdf
 
3.http://www.bidnessetc.com/59228-gilead-sciences-inc-abbvie-inc-finally-see-growth-in-hcv-prescription-volum/
 
EASL: New York Insurers to Change Coverage of Hepatitis C Drugs - (04/26/16)

EASL4

1.Hill A. Minimum Costs for Producing Hepatitis C Direct-Acting Antivirals. Clin Inf Dis. 2014
 
2.
https://www.tga.gov.au/personal-importation-scheme
 
3.https://www.gov.uk/government/organisations/hm-revenue-customs
 

EASL5

EASL6

For interest here is an NMR spectrum of some generic sofosbuvir. NMR is one of a range of techniques, such as High Performance Liquid Chromatography, Mass Spectrometry and X-ray crystallography that can establish the precise nature and purity of a medication.

EASL7

EASL8

EASL9

EASL10